BGL is a founding sponsor and proud Knowledge Partner of DxPx, an annual international partnering conference designed to facilitate financing, business development, and technology scouting opportunities. The conference was founded by startup founders and former industry executives who recognized a need for a dedicated platform for those in Diagnostics, Digital Health, Precision Medicine, and Life Science Tools.
This year’s conference runs from November 15-16, 2022, parallel to MEDICA, the World Forum for Medicine, and brings together growth companies as well as established industry companies and investors in the Dx space.
BGL Managing Director Christoph Brandenberger will be a featured panelist at this year’s conference for a session entitled, “Partnerships in the Life Science Industry: Generating Win-Win Situations for Start-ups and Corporations,” on November 15th from 1 – 1:40 p.m. CEST. The panel will address the benefits and challenges of these partnerships, as well as what it takes to build a mutually beneficial situation for startups and companies.
Additionally, on Day Two of the conference, Christoph will be moderating an exclusive session with QIAGEN entitled, “Licensing Proven Technologies & Validated Biomarkers from QIAGEN: An Opportunity for Value-adding Partnerships,” on November 16th from 4-4:40 p.m. CEST.
BGL’s Diagnostics, Research Tools & Medical Devices team has decades of experience advising all major subsectors of the Diagnostics & Research Tools industry. We maintain active relationships with global industry participants and capital providers and follow regulatory and reimbursement trends; this enables us to not only provide unique access to capital providers, but also the ability to identify and execute on strategic opportunities for our clients.